# Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age

> **NCT03020472** · PHASE4 · TERMINATED · sponsor: **Stanford University** · enrollment: 6 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** 2008-2009 FluMist LAIV (Intranasal)

## Key facts

- **NCT ID:** NCT03020472
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Due to low enrollment
- **Last updated:** 2021-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03020472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03020472, "Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03020472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*